What kind of company is parexel?
biopharmaceutical services
PAREXEL International Corporation is a global biopharmaceutical services The Company provides contract research, consulting, medical communications, and technology solutions. The Company provides its services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Where is parexel based?
Parexel
| Type | Private |
|---|---|
| Headquarters | Durham, North Carolina, U.S. Newton, Massachusetts, U.S. |
| Number of locations | 84+ facilities in 51+ countries |
| Key people | CEO: Jamie Macdonald |
| Services | clinical trial management, data management, medical writing, biostatistics, pharmacovigilance, regulatory consulting |
Who owns parexel?
EQT IX Fund
Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion. Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
Has Parexel been sold?
Parexel sold to EQT and Goldman Sachs for $8.5 billion.
Is Parexel a private company?
Four years after a private equity acquisition took Parexel private, the contract research organization is being acquired by two private equity firms for $8.5 billion. It’s the latest in a series of acquisitions to hit the CRO sector this year.
Is Calyx owned by Parexel?
Calyx will be privately held by the same ownership group that has owned Parexel since 2017. Calyx will be led by Chief Executive Officer Gavin Nichols and the company will be headquartered in Nottingham, United Kingdom, and Durham, North Carolina. The new organization will employ approximately 2,300 employees.
Is Parexel a public company?
The deal comes four years after Parexel was purchased by Pamplona Capital Management for about $5.5 billion, taking the then publicly traded CRO private.
How much is Parexel worth?
Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $88.10 per share in cash, in a transaction valued at approximately $5 billion.
Who will buy Parexel?
EQT IX fund
BOSTON and Durham, N.C. July 2, 2021 — Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, today announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund (“EQT Private …
Has parexel been sold?
Where is PAREXEL located in Billerica, MA?
PAREXEL International 2 Federal St, Billerica, MA 01821 (978) 313-3900
How many employees does PAREXEL International, LLC have?
Parexel International, LLC is located in Billerica, MA, United States and is part of the { {industry}} Industry. Parexel International, LLC has 15000 total employees across all of its locations and generates $639.68 million in sales (USD). There are 170 companies in the Parexel International, LLC corporate family.
Where is PAREXEL International early phase clinical unit located?
Parexel International Early Phase Clinical Unit Harbor Hospital Center, 7th Floor 3001 S. Hanover Street Baltimore, MD 21225 Phone: +1 667 210 5300 Fax: +1 410 354 4281
What do we do at PAREXEL clinical research organization?
At Parexel, we work every day to improve the world’s health. From clinical trials to regulatory, consulting, and market access, every clinical development solution we provide is underpinned by something special – a deep conviction in what we do. We’re not just the people with brains, we’re the people with heart.